H.I.G.-CAPITAL
15.3.2021 12:30:05 CET | Business Wire | Press release
H.I.G. Capital (“H.I.G.“), a leading global alternative investment firm with over €35 billion of equity capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell Infinigate (the “Company”) to Bridgepoint, an international alternative asset fund management group. H.I.G. acquired a majority stake in the Company in 2017. The transaction is subject to clearance by the relevant antitrust authorities.
Infinigate, founded in 1996, is a leading specialized value-added distributor (“VAD”) for cybersecurity and cloud solutions for the SME segment. The core of Infinigate’s business is software distribution – acting as a sales multiplicator between vendors and resellers, giving market access to disruptive vendors, and providing value-added services, such as technical support, trainings, and marketing support to vendors and resellers. Infinigate focuses on strongly growing cybersecurity and cloud segments and supports its multinational software vendors in their expansion throughout Europe by providing a network of more than 10,000 resellers.
With the support of H.I.G., the Company implemented a comprehensive European expansion strategy. Infinigate benefited from H.I.G.’s substantial expertise and extensive network in the technology sector, and from its experience in successfully implementing buy and build strategies. It acquired Dutch cyber security VAD Crypsys in 2017 to expand into the Benelux markets. It subsequently acquired acmeo, a German specialist distributor for the Managed Security Service Provider (“MSSP”) segment to expand into the cloud segment. During the past four years, Infinigate‘s management successfully managed to double the Company’s revenue. Today, the Company has more than 450 employees and is present in eleven European countries – including the DACH region, Benelux, France, the UK and the Nordic countries.
David Martinez, Chairman of the Board and founder of Infinigate, said: ”The close, trusting and successful cooperation with H.I.G. was key for Infinigate to continue its exceptional success story and to tap into additional markets on the continent. Together, we have successfully transformed Infinigate and established the Company as the European leader in the field of cybersecurity solutions. I would like to thank H.I.G. for their support these past few years and look forward to accompany the Company’s next chapter with Bridgepoint, our future investor.”
Klaus Schlichtherle, CEO of Infinigate, added: “Together with H.I.G., we have succeeded in further strengthening Infinigate’s position as a leading VAD in Europe and look forward to partnering with the team at Bridgepoint to continue with our growth strategy and take the business to the next level.”
Dr. Holger Kleingarn, Managing Director at H.I.G., commented: “We are delighted that we were able to support Infinigate on its successful growth trajectory towards a true European market leader. Infinigate demonstrates H.I.G.’s ability to develop companies through a sustainable combination of organic growth and acquisitions. Infinigate is perfectly positioned for further growth on a global scale, and we wish the management team continued success in the future.”
The parties have agreed not to disclose further details of the transaction.
About Infinigate
Infinigate was founded in 1996 as the first European distributor for internet technologies. Since the turn of the millennium, Infinigate has specialized exclusively in the distribution of cyber security solutions for sustainable protection of IT networks, servers, end devices, data and applications. With the acquisition of acmeo, the security competence of the group was extended to the cloud and MSSP (Managed Security Service Providing) business. As a true VAD, Infinigate focuses on innovative and explanation-intensive solutions for enterprises and provides manufacturers and partners (resellers, IT integrators, system houses, etc.) with a range of additional services in the areas of technology, marketing and sales. After several successful market entries and acquisitions, Infinigate intends to continue its geographic expansion strategy. Today, the Infinigate Group has more than 450 employees and is represented by subsidiaries in eleven European countries (Germany, Austria, Switzerland, UK, France, Netherlands, Belgium, Sweden, Norway, Denmark and Finland). Infinigate thus covers more than 80% of the Western European cyber security market potential and has established itself as the leading value-added distributor for cyber security in Europe.
About H.I.G. Capital
H.I.G. is a leading global alternative assets investment firm with over €35 billion of equity capital under management.* Based in Miami, and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro and São Paulo, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/value-added approach:
- H.I.G.’s equity funds invest in management buyouts, recapitalizations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
- H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. is also a leading CLO manager, through its WhiteHorse family of vehicles, and manages a publicly traded BDC, WhiteHorse Finance.
- H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm's current portfolio includes more than 100 companies with combined sales in excess of $30 billion. For more information, please refer to the H.I.G. website at www.higcapital.com .
* Based on total capital commitments managed by H.I.G. Capital and affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210315005381/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
